E. Ohman J:Or Asset Management Ab Alnylam Pharmaceuticals, Inc. Transaction History
E. Ohman J:Or Asset Management Ab
- $3.76 Trillion
- Q1 2025
A detailed history of E. Ohman J:Or Asset Management Ab transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, E. Ohman J:Or Asset Management Ab holds 5,800 shares of ALNY stock, worth $1.39 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
5,800
Previous 6,100
4.92%
Holding current value
$1.39 Million
Previous $1.44 Billion
9.11%
% of portfolio
0.04%
Previous 0.03%
Shares
15 transactions
Others Institutions Holding ALNY
# of Institutions
675Shares Held
108MCall Options Held
839KPut Options Held
771K-
Capital World Investors Los Angeles, CA16.6MShares$3.98 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.06 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.29 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.67 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.05 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $29.5B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...